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The continued use of “percent” in the labelling and description of many drugs used in the field of anaesthesia is an ongoing 
source of errors. As part of the modern drive towards safety in medicine it is proposed that the standard of labelling according to 
mass of the drug per millilitre be universally adopted.
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There are many fields of medicine where small errors may result 
in significant patient harm. Avoidance of sources of 
misunderstanding is a fundamental tenet of error reduction 
strategies.
A recent editorial in the British Journal of Anaesthesia,1 reviewed 
the time-honoured practice of expressing the effective levels of 
physiological gases and volatile anaesthetics in units of “percent” 
or “fractional concentration” (e.g. FiO2) instead of the 
physiologically important variable, partial pressure. The 
nomenclature obscures understanding of the method of action 
of these agents and may thus negatively impact on the safety of 
delivered respiratory gases, especially at sites above sea level. 
While it may be argued that changing this convention will 
require something akin to a seismic shift in the entire industry, 
the continuance of an illogical practice is at odds with the 
growing culture of safety in 21st century medicine.
This discussion also brings to mind the usage of the “percent” 
terminology to express the concentration of drug and electrolyte 
solutions. We propose that this latter usage has an even greater 
potential to increase patient risk - but may also be easily 
remedied. This issue has previously been highlighted.2,3 In this 
editorial, we highlight the errors that may arise from this 
misleading terminology, especially in the calculation of the 
administration of drugs in solution, and the consequent hazards 
across many fields of medical practice.
All but one of the local anaesthetic (LA) solutions available on 
the South African market is labelled with a concentration 
expressed in “percent mass per unit volume – (% m/v)”. When 
implementing an anaesthetic technique involving LA, a 
fundamental risk-reduction strategy is to keep the total amount 
of LA drug administered below a recognised maximum safe dose 
expressed in milligrams per kilogram of patient body mass. If the 
concentration of LA is expressed in milligrams per millilitre (mg/
ml) of solution, the calculation of the maximum safe volume of 
LA solution requires a single multiplication. Thus, any 
administered dose of local anaesthetic agent should be recorded 
in milligrams with the volume administered as a secondary 
descriptor (e.g. 50  mg bupivacaine in 10  ml rather than 10  ml 
0.5% bupivacaine).
However, all but one of the local anaesthetics available in South 
Africa are labelled with a concentration expressed in percent, 
thus making errors in the calculation of a safe dose much more 
likely. As a worked example when calculating the safe amount of 
bupivacaine to be administered:
0.5% bupivacaine = 0.5 g/100 ml = 500 mg/100 ml = 5 mg/ml
Maximum safe dose (plain bupivacaine) = 2 mg/kg = 0.4 ml/kg of 
the above solution.
Numerous errors are possible at any of the above steps, 
particularly those related to factors of ten (vide infra).
The expression of chemical concentration in terms of “percent” is 
ambiguous unless it is qualified. The term can be used to express, 
in percentage terms, the proportion of the mass of substance of 
interest to the total mass of the solution in which it is dissolved 
(% m/m). The term could also be used to express in percentage 
terms the proportion of the volume of the substance to the total 
volume of the solution (% v/v). In both of these instances the 
numerator and denominator share the same units, and thus the 
percentage is (correctly) dimensionless. While neither usage is 
currently highly favoured in laboratory chemistry, these usages 
are mathematically logical.
The biological and pharmaceutical sciences have, unfortunately, 
adopted a third convention: the practice of expressing the 
concentration of dilute solutions in units of grams of solute per 
100  ml of solution, and refer to this as “% m/v”. This usage of 
“percentage” is mathematically bizarre as the numerator and 
denominator are different physical properties, expressed in 
different units, and thus cannot generate a dimensionless value. 
This nomenclature relates rather to the historical choice of the 
decilitre (100 mL) as the volume of solution being studied. It is 
this latter convention that is incorporated into the naming of 
many drugs and electrolyte solutions.
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Our main concern with the continuation of this convention is not 
its inelegance but the way it complicates the education process 
and opens the door for common errors in the order of magnitude,4 
especially in paediatrics.5 The most common source of these 
errors in the order of magnitude is an omitted or misplaced 
decimal point with the addition or omission of a zero following 
closely behind. (“Factor of ten error”)6 As generations of 
anaesthetic trainees have learned by rote, it is necessary for local 
anaesthetics to multiply “% m/v” by a factor of 10 to obtain the 
relevant mg/ml to calculate the maximum safe dose. Omission or 
duplication of this step (both occur) will lead to critical under-
dosing or over-dosing, respectively. Moreover, a significant 
amount of educational time is wasted repeatedly teaching this 
conversion, and the reasons behind it, to trainees at multiple 
levels. Surely this constitutes an unnecessary impediment to 
learning. Expressing dilutions of drugs in terms of the actual 
mass of agent administered and the volume of diluent in which 
it is given is both simpler and safer.
The use of “% m/v” is even more obstructive to understanding 
when used to identify the concentration of electrolyte solutions. 
Conversion of “15% m/v” of potassium chloride into clinically 
usable terms of millimoles per litre requires (for the chemist) 
reference to a periodic table − alternatively (for most clinicians) 
either blind acceptance, rote learning, or (worst of all) ignorance. 
Once again, this convention impairs understanding. Similarly, 
the standard solution of 0.9% sodium chloride requires the user 
to learn and remember that the solution actually contains 
154  mmol/l of sodium and chloride in order to appreciate the 
solute load being administered. This becomes particularly 
important in the understanding of the problem of 
hyperchloraemic acidosis generated by so-called “normal” saline 
infusions.7
Another similar problem occurs during administration of sodium 
bicarbonate, which is sold in two formulations: 4.0% and 8.5% 
m/v.8 Where this formulation deviated from the original 
preparations (4.2% and 8.4%) is unclear. The original purpose of 
the 8.4% formulation was to provide a solution 1  mmol/ml of 
bicarbonate. This allowed the original base excess calculation of 
Astrup and Siggaard-Anderson9 to derive the number of 
millimoles of bicarbonate required by the patient, and for this to 
be administered as a number of millilitres of the 8.4% solution for 
“full” correction and millilitres of the 4.2% solution for “half” 
correction. Given the current controversies over acid base 
management,10 it is perhaps wise to move away from this system 
to one where calculated millimoles of sodium bicarbonate in an 
appropriate solution are judiciously administered in response to 
sequential blood gases, rather than as blind administration of 
various volume amounts.
The problem is yet further compounded when looking at 
intravenous calcium, which is available in two formulations 
(gluconate and chloride) each with very different molar masses. 
However, both solutions are sold in a 10% m/v format and easily 
leads to the assumption that both solutions deliver similar 
quantities of calcium. This assumption is seriously mistaken as 
the gluconate solution has an elemental calcium concentration 
of 9  mg/ml (0.22  mmol) and the chloride solution has an 
elemental calcium concentration of 27 mg/ml (0.68 mmol). This 
represents a threefold difference in administered calcium 
content for the same volume.11 This error is so easy to make that 
noted authors got it wrong in a peer-reviewed article published 
in a major journal.12
Perhaps the most egregious and potentially dangerous of these 
terminological inexactitudes are those referring to adrenaline 
preparations.13 The standard ampoule of adrenaline is widely 
described as “1:1000”, which is, in itself, a meaningless concept. 
What is meant is that the solution contains 1 g of adrenaline in 
1000  ml of solution, or, more usefully, 1  mg (1000  μg) in each 
millilitre. Since dosages of adrenaline should always be described 
in terms of micrograms, the only logical description for the 
standard preparation is 1000  μg/ml. Using this designation 
makes calculation of the required dilutions of adrenaline 
relatively simple, whereas the current practice of describing 
adrenaline mixtures in terms of dilution (1:10,000; 1:100,000; 
etc.) is confusing and prone to massive dosage errors. This leads 
to the further dangerous practice of describing adrenaline 
infusions in terms of millilitres per minute of single, double or 
triple strength adrenaline. This terminology is open to serious 
misunderstanding, especially at hand-overs between staff 
members. The only correct description of an adrenaline infusion 
dose is in terms of microgram/kilogram/minute. The calculation 
of such infusion solutions becomes a simple matter if the starting 
point is to describe the adrenaline in terms of its actual initial 
concentration of 1000  μg/ml. Anything else is potentially 
dangerous and should be abandoned.
A survey conducted in 1995 covering 150 teaching hospitals in 
the United Kingdom found that more than 40% of physicians 
were unable to convert drug doses correctly from percentage 
concentrations to more conventional mass concentrations.14 The 
frequency of reported drug errors amongst South African 
anaesthetists leaves us in no doubt that the situation is no 
different in South Africa today.15 Although this survey focussed 
mainly on the administration of the wrong drug, it also reported 
two deaths related to concentration errors in drug administration.
Expression of drug concentrations in solution in terms of percent 
is clearly misleading and a potential source of error not only in 
anaesthesia but also in all disciplines where drugs in liquid form 
are administered. The industry needs to find the courage to 
move away from this potentially dangerous practice and to use 
scientifically rational and practically useful units – partial 
pressures, mg/ml or mmol/l - instead. We strongly recommend 
that SASA and other professional representative bodies take a 
stance on this critical issue and demand a change in drug 
labelling, mandated through the MCC, as a basic safety issue for 
medical practice in South Africa.
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Erratum:
In the supplement titled Refresher course and main congress texts, which was presented at the annual SASA congress of 2016, the 
following information was documented incorrectly:
• Professor MFM James’s affiliation should be noted as Emeritus Professor of Anaesthesia, University of Cape Town.
• P Motshabi was the only author of the main congress text title “Anaesthesia for non-cardiac surgery for children with known 
congenital heart disease”.
The corrected supplement is available electronically at: http://sajaa.redbricklibrary.com.
